These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4151909)

  • 41. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
    Nakayama K; Oshima T; Koike H
    Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of two cardioselective beta-adrenergic blocking agents: effects on haemodynamic and atrioventricular conduction in man.
    Crouchman M
    Br Heart J; 1973 Aug; 35(8):865. PubMed ID: 4147117
    [No Abstract]   [Full Text] [Related]  

  • 43. Assessment of relative actions of beta-adrenergic blocking drugs on heart rate and left ventricular ejection using a non-invasive method in patients with aortic Starr-Edwards prostheses.
    Crouchman MR
    Br Heart J; 1973 May; 35(5):475-9. PubMed ID: 4146054
    [No Abstract]   [Full Text] [Related]  

  • 44. Relationship between heart rate and ouabain toxicity in the dog heart-lung preparation.
    Lahiri PK; Laddu AR
    Jpn Heart J; 1973 Jul; 14(4):357-65. PubMed ID: 4542950
    [No Abstract]   [Full Text] [Related]  

  • 45. Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
    Yabuuchi Y; Hashimoto K; Yamashita S; Uno T; Shintani S; Nakagiri N
    Clin Exp Pharmacol Physiol; 1977; 4(6):545-59. PubMed ID: 22416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
    Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
    Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of hypothermia and pronethalol on ionic correlates of ouabain arrhythmias in dogs.
    el-Fiky SB; Katzung BG
    Circ Res; 1969 Jan; 24(1):43-50. PubMed ID: 4387675
    [No Abstract]   [Full Text] [Related]  

  • 48. The effects of bretylium on experimental cardiac dysrhythmias.
    Allen JD; Zaidi SA; Shanks RG; Pantridge JF
    Am J Cardiol; 1972 May; 29(5):641-9. PubMed ID: 5021494
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 50. Action of clonidine on baroreceptor reflexes in conscious dogs.
    Walland A; Kobinger W; Csongrady A
    Eur J Pharmacol; 1974 May; 26(2):184-90. PubMed ID: 4152757
    [No Abstract]   [Full Text] [Related]  

  • 51. Mechanism of action of a new adrenergic beta-receptor antagonist MJ 1999 in the prevention of halothane-adrenaline-induced and ouabain-induced ventricular tachycardia in the dog.
    Sharma PL
    Indian J Med Res; 1967 Dec; 55(12):1357-65. PubMed ID: 5595584
    [No Abstract]   [Full Text] [Related]  

  • 52. The antiarrhythmic properties of BL-3677A.
    Buyniski JP; Gardier RW
    J Pharmacol Exp Ther; 1974 Aug; 190(2):289-99. PubMed ID: 4449041
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.
    Cheymol G; Honnorat C; Schmitt H
    Eur J Pharmacol; 1972 Mar; 17(3):341-51. PubMed ID: 4401812
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
    Allen JD; Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1972 Aug; 45(4):561-73. PubMed ID: 5085230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurally induced digitalis arrhythmias and the adrenoceptors.
    Sivam SP; Seth SD; Nayar U; Manchanda SC
    Eur J Pharmacol; 1980 Nov; 68(2):107-15. PubMed ID: 6110541
    [No Abstract]   [Full Text] [Related]  

  • 56. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of prophylactic antiarrhythmic treatment on the incidence of ventricular arrhythmias in the postinfarction period (author's transl)].
    Wolf R; Sinn R; Guillen R
    Z Kardiol; 1982 Jan; 71(1):26-30. PubMed ID: 6175118
    [No Abstract]   [Full Text] [Related]  

  • 58. The activity of beta-adrenoceptor blocking agents in protecting mice from the cardiotoxic effects of ouabain.
    Lavender MK; Parkes MW
    J Pharm Pharmacol; 1973 Apr; 25(4):297-301. PubMed ID: 4146681
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacology of M & B 17803A in man and dog.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1971 Oct; 43(2):468P-469P. PubMed ID: 4400577
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate.
    Billman GE
    J Pharmacol Exp Ther; 1994 Apr; 269(1):409-16. PubMed ID: 7909562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.